Table 2.
Parameter | Month | IAI
|
IVR
|
P-value | ||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | |||
logMAR | 1 | 0.016 | 0.010 | −0.064 | 0.130 | 0.002 |
BCVA change | 2 | −0.012 | 0.118 | −0.084 | 0.155 | 0.017 |
3 | −0.020 | 0.125 | −0.085 | 0.164 | 0.017 | |
TFT change (µm) | 1 | −81 | 108 | −29 | 103 | 0.002 |
2 | −79 | 115 | −49 | 113 | 0.016 | |
3 | −78 | 125 | −52 | 115 | 0.043 | |
FRT change (µm) | 1 | −5 | 60 | −24 | 56 | 0.001 |
2 | −11 | 67 | −21 | 53 | 0.009 | |
3 | −1 | 50 | −18 | 57 | 0.001 | |
HSRD change (µm) | 1 | −85 | 86 | −53 | 84 | 0.008 |
2 | −90 | 93 | −70 | 98 | 0.059 | |
3 | −79 | 111 | −69 | 98 | 0.129 | |
SFCT change (µm) | 1 | −12 | 18 | −7 | 17 | 0.279 |
2 | −33 | 52 | −13 | 23 | 0.003 | |
3 | −27 | 16 | −15 | 24 | <0.001 |
Abbreviations: IAI, intravitreal aflibercept injection; IVR, intravitreal ranibizumab injection; SD, standard deviation; BCVA, best-corrected visual acuity; TFT, total foveal thickness; FRT, foveal retinal thickness; HSRD, height of serous retinal detachment; SFCT, subfoveal choroidal thickness; logMAR, logarithm of the minimum angle of resolution.